Edward W. Harhaj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Edward W. Harhaj has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Noula Shembade
Department of Microbiology & Immunology, Sylvester Comprehensive Cancer Center, The University of Miami, Miller School of Medicine, 1550 NW 10 Avenue, Miami, FL 33136, USA
7 shared publicationsNicole S. Harhaj
Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, The University of Miami, Miller School of Medicine, Miami, Florida 33136
5 shared publicationsKislay Parvatiyar
Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, The University of Miami, Miller School of Medicine, 1550 NW 10 Avenue, Miami, FL 33136, USA
3 shared publicationsNicole S Harhaj
Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, The University of Miami, Miller School of Medicine, Miami, Florida, USA
3 shared publicationsAveril Ma
The ¶Department of Medicine, University of California at San Francisco, San Francisco, California 94143
2 shared publications- Noula Shembade
Department of Microbiology and Immunology, Sylvester Comprehensive Cancer Center, The University of Miami, Miller School of Medicine, Miami, FL 33136, USA
2 shared publications
Latest Publications
- 14 October 2011
- Published by Taylor & Francis in Future Virology
- Vol. 6 (10) , 1165-1168
Outfoxing Foxo Transcription Factors: HTLV-1 Tax Oncoprotein Inactivates FoxO4 Via the Ubiquitin–Proteasome Pathway
Evaluation of: Oteiza A, Mechti N. The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome. J. Virol. 85(13), 6480–6491 (2011). This study examines downstream signaling events of PI3K/AKT in the context of human T cell leukemia virus type 1 (HTLV-1) infection. The authors have demonstrated that the HTLV-1 Tax oncoprotein triggers the ubiquitination and proteasomal degradation of the FoxO4 transcription factor. Phosphorylation by AKT is requisite for Tax-induced FoxO4 degradation since mutation of the AKT phosphorylation sites abrogates FoxO4 degradation. Furthermore, Tax enhances the interaction between FoxO4 and the E3 ubiquitin ligase MDM2 which presumably leads to FoxO4 ubiquitination. Consistently, knockdown of MDM2 with a shRNA plasmid attenuates FoxO4 ubiquitination, revealing an important role for MDM2 in Tax-induced FoxO4 ubiquitination. Finally, Tax represses FoxO4 transcriptional activity in a dose-dependent manner. Taken tog...
- 14 October 2011
- Published by Taylor & Francis in Future Virology
- Vol. 6 (10) , 1165-1168
Outfoxing Foxo Transcription Factors: HTLV-1 Tax Oncoprotein Inactivates FoxO4 Via the Ubiquitin–Proteasome Pathway
Evaluation of: Oteiza A, Mechti N. The human T-cell leukemia virus type 1 oncoprotein tax controls forkhead box O4 activity through degradation by the proteasome. J. Virol. 85(13), 6480–6491 (2011). This study examines downstream signaling events of PI3K/AKT in the context of human T cell leukemia virus type 1 (HTLV-1) infection. The authors have demonstrated that the HTLV-1 Tax oncoprotein triggers the ubiquitination and proteasomal degradation of the FoxO4 transcription factor. Phosphorylation by AKT is requisite for Tax-induced FoxO4 degradation since mutation of the AKT phosphorylation sites abrogates FoxO4 degradation. Furthermore, Tax enhances the interaction between FoxO4 and the E3 ubiquitin ligase MDM2 which presumably leads to FoxO4 ubiquitination. Consistently, knockdown of MDM2 with a shRNA plasmid attenuates FoxO4 ubiquitination, revealing an important role for MDM2 in Tax-induced FoxO4 ubiquitination. Finally, Tax represses FoxO4 transcriptional activity in a dose-dependent manner. Taken tog...
- Open Access
- 1 October 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (42) , 36592-36602
ABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling
- 1 October 2011
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (42) , 36592-36602
Open AccessABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling
- 19 September 2011
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 8 (6) , 447-449
IKKi: a novel regulator of Act1, IL-17 signaling and pulmonary inflammation
- 19 September 2011
- Published by Springer Nature in Cellular & Molecular Immunology
- Vol. 8 (6) , 447-449
IKKi: a novel regulator of Act1, IL-17 signaling and pulmonary inflammation
- 17 July 2011
- Published by Springer Nature in Nature Immunology
- Vol. 12 (9) , 834-843
The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1
The deubiquitinase A20 limits excessive cytokine expression by shutting down activation of the transcription factor NF-κB. Harhaj and colleagues show that the kinase IKKα activates the A20 ubiquitin-editing complex by phosphorylating the regulatory molecule TAX1BP1. In response to stimulation with proinflammatory cytokines, the deubiquitinase A20 inducibly interacts with the regulatory molecules TAX1BP1, Itch and RNF11 to form the A20 ubiquitin-editing complex. However, the molecular signal that coordinates the assembly of this complex has remained elusive. Here we demonstrate that TAX1BP1 was inducibly phosphorylated on Ser593 and Ser624 in response to proinflammatory stimuli. The kinase IKKα, but not IKKβ, was required for phosphorylation of TAX1BP1 and directly phosphorylated TAX1BP1 in response to stimulation with tumor necrosis factor (TNF) or interleukin 1 (IL-1). TAX1BP1 phosphorylation was pivotal for cytokine-dependent interactions among TAX1BP1, A20, Itch and RNF11 and downregulation of signaling by the transcription factor NF-κB. IKKα therefore serves a key role in the negative feedback of NF-κB canonical signaling by orchestrating assembly of the A20 ubiquitin-editing complex to limit inflammatory gene activation.
- 17 July 2011
- Published by Springer Nature in Nature Immunology
- Vol. 12 (9) , 834-843
The kinase IKKα inhibits activation of the transcription factor NF-κB by phosphorylating the regulatory molecule TAX1BP1
The deubiquitinase A20 limits excessive cytokine expression by shutting down activation of the transcription factor NF-κB. Harhaj and colleagues show that the kinase IKKα activates the A20 ubiquitin-editing complex by phosphorylating the regulatory molecule TAX1BP1. In response to stimulation with proinflammatory cytokines, the deubiquitinase A20 inducibly interacts with the regulatory molecules TAX1BP1, Itch and RNF11 to form the A20 ubiquitin-editing complex. However, the molecular signal that coordinates the assembly of this complex has remained elusive. Here we demonstrate that TAX1BP1 was inducibly phosphorylated on Ser593 and Ser624 in response to proinflammatory stimuli. The kinase IKKα, but not IKKβ, was required for phosphorylation of TAX1BP1 and directly phosphorylated TAX1BP1 in response to stimulation with tumor necrosis factor (TNF) or interleukin 1 (IL-1). TAX1BP1 phosphorylation was pivotal for cytokine-dependent interactions among TAX1BP1, A20, Itch and RNF11 and downregulation of signaling by the transcription factor NF-κB. IKKα therefore serves a key role in the negative feedback of NF-κB canonical signaling by orchestrating assembly of the A20 ubiquitin-editing complex to limit inflammatory gene activation.
- 15 July 2011
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (14) , 6955-6962
Human T Cell Leukemia Virus Type 1 Tax Inhibits Innate Antiviral Signaling via NF-κB-Dependent Induction of SOCS1
Human T cell leukemia virus type 1 (HTLV-1) inhibits host antiviral signaling pathways although the underlying mechanisms are unclear. Here we found that the HTLV-1 Tax oncoprotein induced the expression of SOCS1, an inhibitor of interferon signaling. Tax required NF-κB, but not CREB, to induce the expression of SOCS1 in T cells. Furthermore, Tax interacted with SOCS1 in both transfected cells and in HTLV-1-transformed cell lines. Although SOCS1 is normally a short-lived protein, in the presence of Tax, the stability of SOCS1 was greatly increased. Accordingly, Tax enhanced the replication of a heterologous virus, vesicular stomatitis virus (VSV), in a SOCS1-dependent manner. Surprisingly, Tax required SOCS1 to inhibit RIG-I-dependent antiviral signaling, but not the interferon-induced JAK/STAT pathway. Inhibition of SOCS1 by RNA-mediated interference in the HTLV-1-transformed cell line MT-2 resulted in increased IFN-β expression accompanied by reduced HTLV-1 replication and p19 Gag levels. Taken together, our results reveal that Tax inhibits antiviral signaling, in part, by hijacking an interferon regulatory protein.
- 15 July 2011
- Published by American Society for Microbiology in Journal of Virology
- Vol. 85 (14) , 6955-6962
Human T Cell Leukemia Virus Type 1 Tax Inhibits Innate Antiviral Signaling via NF-κB-Dependent Induction of SOCS1
Human T cell leukemia virus type 1 (HTLV-1) inhibits host antiviral signaling pathways although the underlying mechanisms are unclear. Here we found that the HTLV-1 Tax oncoprotein induced the expression of SOCS1, an inhibitor of interferon signaling. Tax required NF-κB, but not CREB, to induce the expression of SOCS1 in T cells. Furthermore, Tax interacted with SOCS1 in both transfected cells and in HTLV-1-transformed cell lines. Although SOCS1 is normally a short-lived protein, in the presence of Tax, the stability of SOCS1 was greatly increased. Accordingly, Tax enhanced the replication of a heterologous virus, vesicular stomatitis virus (VSV), in a SOCS1-dependent manner. Surprisingly, Tax required SOCS1 to inhibit RIG-I-dependent antiviral signaling, but not the interferon-induced JAK/STAT pathway. Inhibition of SOCS1 by RNA-mediated interference in the HTLV-1-transformed cell line MT-2 resulted in increased IFN-β expression accompanied by reduced HTLV-1 replication and p19 Gag levels. Taken together, our results reveal that Tax inhibits antiviral signaling, in part, by hijacking an interferon regulatory protein.
- 1 March 2011
- Published by Elsevier in Microbes and Infection
- Vol. 13 (3) , 209-215
Regulation of inflammatory and antiviral signaling by A20
- 1 March 2011
- Published by Elsevier in Microbes and Infection
- Vol. 13 (3) , 209-215
Regulation of inflammatory and antiviral signaling by A20
- 30 November 2010
- Published by Springer Nature in Cell Research
- Vol. 21 (1) , 22-39
Deubiquitinases in the regulation of NF-κB signaling
Nuclear factor-kappa B (NF-κB) is a critical regulator of multiple biological functions including innate and adaptive immunity and cell survival. Activation of NF-κB is tightly regulated to preclude chronic signaling that may lead to persistent inflammation and cancer. Ubiquitination of key signaling molecules by E3 ubiquitin ligases has emerged as an important regulatory mechanism for NF-κB signaling. Deubiquitinases (DUBs) counteract E3 ligases and therefore play a prominent role in the downregulation of NF-κB signaling and homeostasis. Understanding the mechanisms of NF-κB downregulation by specific DUBs such as A20 and CYLD may provide therapeutic opportunities for the treatment of chronic inflammatory diseases and cancer.
- 30 November 2010
- Published by Springer Nature in Cell Research
- Vol. 21 (1) , 22-39
Deubiquitinases in the regulation of NF-κB signaling
Nuclear factor-kappa B (NF-κB) is a critical regulator of multiple biological functions including innate and adaptive immunity and cell survival. Activation of NF-κB is tightly regulated to preclude chronic signaling that may lead to persistent inflammation and cancer. Ubiquitination of key signaling molecules by E3 ubiquitin ligases has emerged as an important regulatory mechanism for NF-κB signaling. Deubiquitinases (DUBs) counteract E3 ligases and therefore play a prominent role in the downregulation of NF-κB signaling and homeostasis. Understanding the mechanisms of NF-κB downregulation by specific DUBs such as A20 and CYLD may provide therapeutic opportunities for the treatment of chronic inflammatory diseases and cancer.
- 1 July 2010
- Published by Taylor & Francis in Cell Cycle
- Vol. 9 (13) , 2481-2482
A20 inhibition of NFκB and inflammation: Targeting E2:E3 ubiquitin enzyme complexes
Comment on: Shembade N, Ma A, Harhaj EW. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010; 327:1135-9.
- 1 July 2010
- Published by Taylor & Francis in Cell Cycle
- Vol. 9 (13) , 2481-2482
A20 inhibition of NFκB and inflammation: Targeting E2:E3 ubiquitin enzyme complexes
Comment on: Shembade N, Ma A, Harhaj EW. Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 2010; 327:1135-9.
- Open Access
- 1 May 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (20) , 14999-15009
TAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases
- 1 May 2010
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 285 (20) , 14999-15009
Open AccessTAX1BP1 and A20 Inhibit Antiviral Signaling by Targeting TBK1-IKKi Kinases
- 26 February 2010
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 327 (5969) , 1135-1139
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Limiting Inflammatory Signaling: Dysregulation of the transcription factor NF-κB causes chronic inflammation, autoimmunity, and malignancy. The zinc-finger protein, A20, is vital for regulating NF-κB signaling, so much so that mice lacking A20 die young of multiorgan failure and cachexia. Similar deficiencies have been seen in Crohn's disease, rheumatoid arthritis, and other inflammatory diseases of humans. But how A20 works has remained unknown. Shembade et al. (p. 1135 ; see the Perspective by S riskantharajah and Ley ) have discovered that the A20 protein acts through the ubiquitin labeling system of the cell required for normal protein turnover, and its lack prevents NF-κB recycling, resulting in chronic inflammation. A human T cell lymphotropic virus possesses an oncoprotein that subverts this pathway to the virus' benefit by inhibiting A20 interactions with the ubiquitin pathway to promote NF-κB signaling and cell immortalization.
- 26 February 2010
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 327 (5969) , 1135-1139
Inhibition of NF-κB Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
Limiting Inflammatory Signaling: Dysregulation of the transcription factor NF-κB causes chronic inflammation, autoimmunity, and malignancy. The zinc-finger protein, A20, is vital for regulating NF-κB signaling, so much so that mice lacking A20 die young of multiorgan failure and cachexia. Similar deficiencies have been seen in Crohn's disease, rheumatoid arthritis, and other inflammatory diseases of humans. But how A20 works has remained unknown. Shembade et al. (p. 1135 ; see the Perspective by S riskantharajah and Ley ) have discovered that the A20 protein acts through the ubiquitin labeling system of the cell required for normal protein turnover, and its lack prevents NF-κB recycling, resulting in chronic inflammation. A human T cell lymphotropic virus possesses an oncoprotein that subverts this pathway to the virus' benefit by inhibiting A20 interactions with the ubiquitin pathway to promote NF-κB signaling and cell immortalization.